COAG
Hemab Therapeutics Holdings, Inc.
30.60$
-1.7%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 25 | Q2 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|
| – | – | – | – | |
| – | – | – | – | |
| – | – | – | – | |
| – | -8.7% | +51.2% | +4.5% | |
| – | +29.4% | +30.4% | +38.4% | |
| – | -3.0% | +47.1% | +10.4% | |
| – | – | – | – | |
| – | – | – | – | |
| – | – | – | +708.3% | |
| – | – | – | – | |
| – | – | – | – |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.